Additionally, a case report described a patient with HER-2-positive metastatic gastroesophageal junction adenocarcinoma treated with cadonilimab in combination with chemotherapy, resulting in complete remission (CR) (9). The gene discussed is ERBB2; the disease is gastroesophageal junction adenocarcinoma.